Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Fenaux

Showing results (61-70 of 432) with videos related to

Pageof 44
Sort By:
Blood|May 3, 2002
Unlike AML1, CBFbeta gene is not deregulated by point mutations in acute myeloid leukemia and in myelodysplastic syndromesHugues Leroy, Christophe Roumier, Nathalie Grardel-Duflos, et al.
Bulletin Du Cancer|July 6, 2023
[Dysimmune manifestations associated with myelodysplastic neoplasms and chronic myelomonocytic leukaemias]Vincent Jachiet, Jérôme Hadjadj, Lin-Pierre Zhao, et al.
Leukemia Research|June 17, 2008
Cytogenetic abnormalities in Tunisian de novo myelodysplastic syndrome: a comparison with other populationsAbir Gmidène, Hlima Sennana, Pierre Fenaux, et al.
British Journal of Haematology|December 15, 2018
Clinical effectiveness and safety of erythropoietin-stimulating agents for the treatment of low- and intermediate-1-risk myelodysplastic syndrome: a systematic literature reviewSophie Park, Peter Greenberg, Aylin Yucel, et al.
Leukemia Research|April 9, 2015
Question prompt list responds to information needs of myelodysplastic syndromes patients and caregiversJulien Mancini, Phyllis N Butow, Claire Julian-Reynier, et al.
British Journal of Haematology|May 24, 2016
Efficacy and safety of darbepoetin alpha in patients with myelodysplastic syndromes: a systematic review and meta-analysisSophie Park, Pierre Fenaux, Peter Greenberg, et al.
Cancer Genetics and Cytogenetics|February 22, 2005
Role of multiplex FISH in identifying chromosome involvement in myelodysplastic syndromes and acute myeloid leukemias with complex karyotypes: a report on 28 casesEmmanuelle Barouk-Simonet, Valérie Soenen-Cornu, Christophe Roumier, et al.
Leukemia & Lymphoma|February 18, 2020
Achievement of red blood cell transfusion independence in red blood cell transfusion-dependent patients with lower-risk non-del(5q) myelodysplastic syndromes correlates with serum erythropoietin levelsValeria Santini, Antonio Almeida, Aristoteles Giagounidis, et al.
Leukemia Research|December 3, 2014
Minimizing risk of hypomethylating agent failure in patients with higher-risk MDS and practical management recommendationsValeria Santini, Thomas Prebet, Pierre Fenaux, et al.
Leukemia Research|August 15, 2015
Comparison of TP53 mutations screening by functional assay of separated allele in yeast and next-generation sequencing in myelodysplastic syndromesCécile Bally, Aline Renneville, Claude Preudhomme, et al.
Pageof 44

Showing results (61-70 of 432) with videos related to

Sort By:
Pageof 44
Blood|May 3, 2002
Unlike AML1, CBFbeta gene is not deregulated by point mutations in acute myeloid leukemia and in myelodysplastic syndromesHugues Leroy, Christophe Roumier, Nathalie Grardel-Duflos, et al.
Bulletin Du Cancer|July 6, 2023
[Dysimmune manifestations associated with myelodysplastic neoplasms and chronic myelomonocytic leukaemias]Vincent Jachiet, Jérôme Hadjadj, Lin-Pierre Zhao, et al.
Leukemia Research|June 17, 2008
Cytogenetic abnormalities in Tunisian de novo myelodysplastic syndrome: a comparison with other populationsAbir Gmidène, Hlima Sennana, Pierre Fenaux, et al.
British Journal of Haematology|December 15, 2018
Clinical effectiveness and safety of erythropoietin-stimulating agents for the treatment of low- and intermediate-1-risk myelodysplastic syndrome: a systematic literature reviewSophie Park, Peter Greenberg, Aylin Yucel, et al.
Leukemia Research|April 9, 2015
Question prompt list responds to information needs of myelodysplastic syndromes patients and caregiversJulien Mancini, Phyllis N Butow, Claire Julian-Reynier, et al.
British Journal of Haematology|May 24, 2016
Efficacy and safety of darbepoetin alpha in patients with myelodysplastic syndromes: a systematic review and meta-analysisSophie Park, Pierre Fenaux, Peter Greenberg, et al.
Cancer Genetics and Cytogenetics|February 22, 2005
Role of multiplex FISH in identifying chromosome involvement in myelodysplastic syndromes and acute myeloid leukemias with complex karyotypes: a report on 28 casesEmmanuelle Barouk-Simonet, Valérie Soenen-Cornu, Christophe Roumier, et al.
Leukemia & Lymphoma|February 18, 2020
Achievement of red blood cell transfusion independence in red blood cell transfusion-dependent patients with lower-risk non-del(5q) myelodysplastic syndromes correlates with serum erythropoietin levelsValeria Santini, Antonio Almeida, Aristoteles Giagounidis, et al.
Leukemia Research|December 3, 2014
Minimizing risk of hypomethylating agent failure in patients with higher-risk MDS and practical management recommendationsValeria Santini, Thomas Prebet, Pierre Fenaux, et al.
Leukemia Research|August 15, 2015
Comparison of TP53 mutations screening by functional assay of separated allele in yeast and next-generation sequencing in myelodysplastic syndromesCécile Bally, Aline Renneville, Claude Preudhomme, et al.
Pageof 44